Shared Care Guidelines
Melatonin for the treatment of Insomnia and Sleep Disorders in Children and Adolescents – Shared care guideline
Update Dec 2024
The formulary status of melatonin for use in children and adolescents has changed with BLMK – it is now designated as AMBER SpIS i.e. requires specialist initiation and stabilisation, followed by GP Prescribing in this patient group.
The shared care guideline has been replaced with a Melatonin Prescribing Support Information document – for use in Children & Young People
Guideline Categories: Miscellaneous
Guideline Areas: Bedfordshire, Luton
Guideline Tags: adolescents, Children, insomnia, melatonin, sleep
Please use the search box to search the whole site if you can't find what you're looking for:
